DalCor Pharmaceuticals Stock

dalcorpharma.comHealthcareFounded: 2015

DalCor develops precision treatments for cardiovascular disease by genetically targeting patients that will derive clinical benefits.

Register for Details

For more details on financing and valuation for DalCor Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for DalCor Pharmaceuticals.

Register Today

Other companies like DalCor Pharmaceuticals in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector